An Inside Look at Apple’s Biggest Step Yet in Health Care image

Time, December 6, 2018
by Alex Fitzpatrick, quoting W. Nicholson Price (Academic Fellow Alumnus)

Links

Read the Full Article

From the article:

"In the long run, however, it’s privacy concerns that have the biggest potential to hamper tech companies’ health dreams. News of data breaches that expose consumers’ personal information have become practically routine. Some 23andMe customers have already expressed outrage over the GlaxoSmithKline deal, which in part gives the pharma giant access to 23andMe users’ anonymized data for drug targeting. Facebook’s hospital data-sharing idea was shelved after the Cambridge Analytica scandal, which convinced many everyday social-media users to reconsider what data they’re sharing and with whom they’re sharing it.

Yet some of the most powerful advances in health could come from taking the data from all of these individual users and mining it for new discoveries. “I’m hopeful and optimistic that if we collect lots of data, put it all together and crunch our way through it, we’ll find out useful and interesting things, be able to improve health and all these really good things,” says Nicholson Price, assistant professor of law at the University of Michigan Law School. “The negative side of that of course is what it always is, which is that Big Data is great for selling people stuff.”

Read more here!

ai health law policy regulation